| Financial Year |
March 31 2023 |
| Monetary Funds |
2,338,123,228.15 |
| Held-for-trading Financial Assets |
3,354,019,385.06 |
| Notes Receivable |
362,422.50 |
| Accounts Receivable |
142,321,390.05 |
| Advances to Suppliers |
13,833,847.82 |
| Other Receivables |
7,022,347.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
52,489,659.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,964,446.63 |
| Total Current Assets |
5,922,136,726.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
148,967,555.83 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,269,854.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
47,748,912.13 |
| Deferred Income Tax Assets |
77,029,526.37 |
| Other Non-Current Assets |
196,571,182.00 |
| Sub-Total of Non-Current Assets |
723,371,383.18 |
| Total Assets |
6,645,508,110.09 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
26,068,184.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,377,570.48 |
| Taxes Payable |
16,404,355.07 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,419,625.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,749,270.00 |
| Other Current Liabilities |
1,243,090.24 |
| Sub-Total of Current Liabilities |
124,862,443.29 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
24,171,489.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
69,014,727.24 |
| Total Liabilities |
193,877,170.53 |
| Paid-In Capital(Or Share Stock) |
129,200,000.00 |
| Capital Surplus |
4,793,989,139.63 |
| Surplus Reserve |
64,600,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,451,475,003.25 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,451,630,939.56 |
| Owner's Equity（Stockholder's Equity） |
6,451,630,939.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,645,508,110.09 |
